Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03120988 · ClinicalTrials.gov registry record · Phase 1
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
A Phase 1 study of Knee Osteoarthritis, sponsored by Regenexx.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03120988: Completed Phase 1 study of Knee Osteoarthritis, sponsored by Regenexx.
NCT03120988 is a Phase 1 study of Knee Osteoarthritis that has completed, run by Regenexx. The registered enrollment target is 10 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03120988, a Phase 1 study of Knee Osteoarthritis, has completed, sponsored by Regenexx.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how the components of osteoarthritic knee joint fluid (synovial fluid) change after lavage treatment with platelet poor plasma. Additionally, the study participants will complete outcome questionnaire surveys before and after the treatment in conjunction with when synovial fluid is removed from the knee (2, 4, and 6 weeks after lavage). This data will help determine if the treatment of an osteoarthritic knee joint with platelet poor plasma lavage is a suitable stand-alone therapy or to improve outcome by preparing a patient's knee for further regenerative therapies.
Conditions Studied
Interventions
- BIOLOGICAL Lavage with Platelet Poor Plasma (PPP)
Study Locations (1)
Colorado
- Centeno-Schultz Clinic - Broomfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-12 |
| Phase | Phase 1 |
What the finished NCT03120988 record still lists
NCT03120988 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Lavage with Platelet Poor Plasma (PPP) is the first listed.
NCT03120988 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03120988 about?
NCT03120988 is a clinical study titled "Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage". The purpose of this study is to understand how the components of osteoarthritic knee joint fluid (synovial fluid) change after lavage treatment with platelet poor plasma. Additionally, the study participants will complete outcome questionnaire surveys before and after the treatment in conjunction wi...
What is the current status of trial NCT03120988?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2016-07. Estimated completion is 2017-12.
What conditions does trial NCT03120988 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT03120988?
The interventions under investigation include: Lavage with Platelet Poor Plasma (PPP) (BIOLOGICAL).
Who is sponsoring clinical trial NCT03120988?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03120988 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03120988's enrollment target sits among peer trials
10 101st of 101 higher than 1 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis
RECRUITING · Phase 1
-
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis
COMPLETED · Phase 1
-
Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis
COMPLETED · Phase 1
-
Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia